A recent study indicates that people who discontinue popular slimming jabs like Mounjaro or Wegovy can put back on shed pounds far faster than those who stop conventional diet and exercise programs.
Research printed in a leading health publication demonstrates that while overweight people often shed substantial amounts of their total mass while on the medication, the mass comes back at an average rate of 0.8 kg per month after stopping.
"Users buying such medications must be informed of the danger of quick weight regain when the medication ends," stated expert Dr. Susan Jebb.
That rate of regain implies a reversion to pre-treatment mass in about 18 months.
Weighing Treatments
The research, which looked at 37 of trials involving over 9,000 of patients, compared the outcomes of these new drugs with other pills.
Scientists note that people who shed pounds through dieting typically have a more gradual weight regain—perhaps 100 grams monthly—after stopping.
Understanding the Rapid Rebound
Experts suggest the mechanism of the jabs is key to understanding the accelerated weight return.
These medications imitate a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.
"Artificially providing GLP-1 levels several times higher than normal might result in the body to produce less of its endogenous hormone, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' results in appetite is no longer kept in check, making overeating a significant risk."
An Ongoing Issue?
Health authorities advise the jabs for people with obesity-related medical conditions, alongside prescribed lifestyle changes.
A number of clinicians argue that, due to the high risk of relapse, the treatment might need to be life-long.
This opinion is reinforced by drug manufacturers, who state that the results "highlight the persistent character of obesity," akin to managing conditions like hypertension.
Patient Testimonies
Individuals who have stopped the jabs describe a intense resurgence of appetite.
"It felt as if a trigger activating and I was suddenly starving," described an individual.
The struggle is compounded if individuals have not established permanent lifestyle or habit modifications during therapy.
Growing Use
Recent estimates show that a significant number of adults in the UK have used these injections in the last 12 months, with desire being substantial.
- Use is more common among females compared to men.
- The middle-aged demographic shows the greatest level of interest.
- Many access the drugs through private healthcare rather than public health services.
In conclusion, experts stress that while GLP-1 drugs are powerful tools for shedding pounds, they are not a standalone solution and maintained weight loss hinges on ongoing behavioural management.
